Search

everythinglearnresearchcommunity

for

Search:↓

Hair science has grown significantly, focusing on conditions like alopecia and improving treatments and techniques.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 survivors may face long-term health issues affecting both mind and body.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

COVID-19 doesn't make alopecia areata worse.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

COVID-19 may trigger alopecia areata, but more research is needed.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

Post-COVID-19 hair loss is likely due to stress and inflammation.

The pandemic stress may have increased alopecia cases in Bangladesh.

Topical Minoxidil is effective for hair loss after COVID-19.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

COVID-19 infection may trigger alopecia areata in some patients.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.